Showing results (1-10 of 4,761) with videos related to

Sort By:
Pageof 477
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 20, 2003
Fatigue associated with multiple sclerosis: diagnosis, impact and managementRohit Bakshi
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 20, 2003
Long-term follow up of patients with clinically isolated syndromes, relapsing-remitting and secondary progressive multiple sclerosisMaja Eriksson, Oluf Andersen, Björn Runmarker
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 20, 2003
Somatosensory evoked potentials and sensory involvement in multiple sclerosis: comparison with clinical findings and quantitative sensory testsLetizia Leocani, Vittorio Martinelli, Maria Grazia Natali-Sora, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 20, 2003
Unconventional therapy in multiple sclerosisJaume Sastre-Garriga, Elvira Munteis, Jordi Río, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 18, 2011
Long-term safety profile of mitoxantrone in a French cohort of 802 multiple sclerosis patients: a 5-year prospective studyE Le Page, E Leray, G Edan, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 14, 2011
Intracranial venous pressure is normal in patients with multiple sclerosisRolf Meyer-Schwickerath, Christian Haug, Annette Hacker, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 14, 2011
Safety and tolerability of cladribine tablets in multiple sclerosis: the CLARITY (CLAdRIbine Tablets treating multiple sclerosis orallY) studyS Cook, P Vermersch, G Comi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 24, 2010
An approach to natalizumab hypersensitivity: a case series of induction of toleranceMarie Camacho-Halili, Roxanne George, Malcolm Gottesman, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 24, 2010
A functional magnetic resonance proof of concept pilot trial of cognitive rehabilitation in multiple sclerosisJ Sastre-Garriga, J Alonso, M Renom, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 24, 2011
PARP-1 inhibition prevents CNS migration of dendritic cells during EAE, suppressing the encephalitogenic response and relapse severityLeonardo Cavone, Alessandra Aldinucci, Clara Ballerini, et al.
Pageof 477